SCHEMBL5507574

SCHEMBL5507574

N#Cc1ccc2cccc(NC(=O)CCC3CCCNC3)c2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.43
ROCK2 O75116 4/20 0.43
ALDH1A1 P00352 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 1/20 0.41
NFKB1 P19838 1/20 0.41
RAB9A P51151 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA4 P43681 1/20 0.39
PKN2 Q16513 1/20 0.39
MEN1 O00255 2/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5511359 0.76 CYP2C9 (0.43) KMT2AALDH1A1MEN1HTR6MAPT
SCHEMBL6508976 0.72 KMT2A (0.67) KMT2AROCK2ALDH1A1SMN1; SMN2NPC1
SCHEMBL30685736 0.70 POLB (0.64) KMT2AALDH1A1SMN1; SMN2NPC1HPGD
SCHEMBL31227621 0.70 KMT2A (0.60) KMT2AROCK2ALDH1A1CHRNB2CHRNB4
SCHEMBL306802 0.69 ROCK2 (0.61) KMT2AROCK2ALDH1A1SMN1; SMN2PKN2
SCHEMBL5511934 0.68 ROCK2 (0.46) KMT2AROCK2ALDH1A1SMN1; SMN2NPC1
SCHEMBL31227953 0.67 P2RX7 (0.56) KMT2AROCK2NPC1RAB9AMEN1
SCHEMBL31227757 0.67 P2RX7 (0.56) KMT2AROCK2ALDH1A1NPC1HPGD
SCHEMBL306941 0.67 ROCK2 (0.73) KMT2AROCK2PKN2CYP3A4CYP2C19
SCHEMBL7567808 0.65 KMT2A (0.60) KMT2AROCK2CHRNB2CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799676-A2 NEW BICYCLIC ANTIBIOTICS Actelion Pharmaceuticals Ltd. (CH) 2007-06-27 EP disclosed
WO-2006032466-A2 NEW BICYCLIC ANTIBIOTICS ACTELION PHARMACEUTICALS LTD (CH) 2006-03-30 WO disclosed